ReviewCell reports. Medicine2026

Individualized antisense oligonucleotide treatment eligibility of patients living with neurodevelopmental diseases.

Annemieke Aartsma-Rus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.